VKTX Viking Therapeutics RESULTS: Q2, Q2 EPS $-1.1 vs. EST $-1.25, Q2 Income from operations $-132.597M vs. EST $-150.3M, Q2 Net Income $-12
VKTX Viking Therapeutics RESULTS: Q2, Q2 EPS $-1.1 vs. EST $-1.25, Q2 Income from operations $-132.597M vs. EST $-150.3M, Q2 Net Income $-128.022M vs. EST $-144.7M, Q2 operating expenses $132.597M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.